Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of a Single Infusion of Bezlotoxumab (MK-6072, Human Monoclonal Antibody to C. difficile Toxin B) in Children

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date02/26/18 → 02/25/21

Funding

  • Merck Sharp and Dohme Limited Liability Corporation: $11,000.00